Related Experiment Videos
Alpha-adrenoceptor antagonists in neurogenic lower urinary tract dysfunction.
1Bristol Urological Institute, Southmead Hospital, United Kingdom.
Urology
|March 27, 1999
Summary
Alpha blockers may offer a small benefit for neurogenic lower urinary tract dysfunction, aiding bladder storage, emptying, and preventing autonomic dysreflexia. Further research with larger trials is needed to confirm their role.
Area of Science:
- Neurology
- Urology
- Pharmacology
Background:
- Lower urinary tract dysfunction (LUTD) is a frequent and serious complication in neurological diseases.
- Current treatments for neurogenic LUTD often have limitations.
Purpose of the Study:
- To evaluate the efficacy of alpha-adrenoceptor antagonists (alpha blockers) in managing neurogenic lower urinary tract dysfunction.
- To assess the potential benefits of alpha blockers in improving bladder storage, emptying, and preventing autonomic dysreflexia.
Main Methods:
- Review of existing clinical trials, including small, nonrandomized, and uncontrolled studies.
- Analysis of the reported effects of alpha blockers on lower urinary tract symptoms and complications.
Main Results:
- Alpha blockers demonstrate a potentially small but useful effect in facilitating bladder storage and emptying.
- Evidence suggests alpha blockers may help prevent autonomic dysreflexia in patients with neurogenic LUTD.
Conclusions:
- Alpha blockers may offer a therapeutic option for neurogenic lower urinary tract dysfunction.
- Larger, randomized clinical trials with extended follow-up are necessary to fully elucidate the role of alpha blockers.